ORI
Oak Ridge Investments Portfolio holdings
AUM
$1.39B
This Quarter Return
+11.98%
1 Year Return
+33.33%
3 Year Return
+165.84%
5 Year Return
+254.68%
10 Year Return
+830.04%
AUM
$1.18B
AUM Growth
+$1.18B
(+4.3%)
Cap. Flow
-$49.6M
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
31.98%
Holding
188
New
15
Increased
13
Reduced
138
Closed
21
Top Buys
| 1 |
Tesla
TSLA
|
$11.9M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$10.3M |
| 3 |
TechTarget
TTGT
|
$9.14M |
| 4 |
Lantheus
LNTH
|
$8.24M |
| 5 |
AZEK
The AZEK Co
AZEK
|
$7.76M |
Top Sells
| 1 |
LHCG
LHC Group LLC
LHCG
|
$11.8M |
| 2 |
EPAM Systems
EPAM
|
$9.98M |
| 3 |
Salesforce
CRM
|
$9.12M |
| 4 |
Qualcomm
QCOM
|
$8.73M |
| 5 |
EVBG
Everbridge, Inc. Common Stock
EVBG
|
$8.6M |
Sector Composition
| 1 | Technology | 36.46% |
| 2 | Healthcare | 18.19% |
| 3 | Consumer Discretionary | 13% |
| 4 | Industrials | 11.31% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Equinix
EQIX
$76.9B
| $5.28M | 0.45% |
6,237
-102
| -2% | -$86.3K |
|
77
Euronet Worldwide
EEFT
$3.82B
| $5.04M | 0.43% |
42,303
-2,762
| -6% | -$329K |
|
78
Wingstop
WING
$9.16B
| $4.73M | 0.4% |
27,354
-460
| -2% | -$79.5K |
|
79
argenx
ARGX
$43.6B
| $4.72M | 0.4% |
13,473
-234
| -2% | -$81.9K |
|
80
Travere Therapeutics
TVTX
$1.56B
| $4.63M | 0.39% |
149,077
-2,762
| -2% | -$85.7K |
|
|
BHVN
81
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.6M | 0.39% |
33,395
-570
| -2% | -$78.5K |
|
82
TransUnion
TRU
$17.2B
| $4.45M | 0.38% |
37,487
-6,608
| -15% | -$784K |
|
83
Veracyte
VCYT
$2.39B
| $4.44M | 0.38% |
107,848
-1,818
| -2% | -$74.9K |
|
84
Edwards Lifesciences
EW
$47.8B
| $4.38M | 0.37% |
33,795
-526
| -2% | -$68.1K |
|
85
Kinsale Capital Group
KNSL
$10.7B
| $4.37M | 0.37% |
18,376
-975
| -5% | -$232K |
|
86
Marsh & McLennan
MMC
$101B
| $4.25M | 0.36% |
24,469
-368
| -1% | -$64K |
|
87
Ollie's Bargain Outlet
OLLI
$7.78B
| $4.24M | 0.36% |
82,802
-4,591
| -5% | -$235K |
|
88
Nike
NKE
$114B
| $4.17M | 0.35% |
+24,995
| New | +$4.17M |
|
89
Penumbra
PEN
$10.6B
| $4.03M | 0.34% |
14,014
-224
| -2% | -$64.4K |
|
90
AstraZeneca
AZN
$248B
| $3.92M | 0.33% |
67,379
+8,735
| +15% | +$509K |
|
91
Arrowhead Research
ARWR
$3.05B
| $3.83M | 0.32% |
57,824
-1,009
| -2% | -$66.9K |
|
92
Charter Communications
CHTR
$36.3B
| $3.54M | 0.3% |
5,436
-78
| -1% | -$50.9K |
|
93
Aurinia Pharmaceuticals
AUPH
$1.58B
| $3.49M | 0.3% |
+152,735
| New | +$3.49M |
|
94
Unilever
UL
$155B
| $3.49M | 0.29% |
64,917
-3,238
| -5% | -$174K |
|
95
Grocery Outlet
GO
$1.78B
| $3.47M | 0.29% |
122,653
-13,314
| -10% | -$376K |
|
96
Fidelity National Information Services
FIS
$36.5B
| $3.47M | 0.29% |
31,762
-1,050
| -3% | -$115K |
|
97
Palomar
PLMR
$3.29B
| $3.33M | 0.28% |
51,435
-3,004
| -6% | -$195K |
|
98
lululemon athletica
LULU
$24.2B
| $3.11M | 0.26% |
+7,937
| New | +$3.11M |
|
99
OrthoPediatrics
KIDS
$536M
| $3M | 0.25% |
50,071
-824
| -2% | -$49.3K |
|
|
BPMC
100
DELISTED
Blueprint Medicines
BPMC
| $2.88M | 0.24% |
26,904
-445
| -2% | -$47.7K |
|